§ BIOTECHNOLOGY
USD · BiotechnologyAVTX
AVALO THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
104 increased/new, 25 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 2.9M | 0.0% | +1207% |
| Caligan Partners LP | 1.6M | 1.6% | +85% |
| BVF INC/IL | 1.6M | 0.8% | +20% |
| Avoro Capital Advisors LLC | 1.4M | 0.2% | n/a |
| Affinity Asset Advisors, LLC | 1.3M | 1.0% | +28% |
| Nantahala Capital Management, LLC | 1.2M | 0.7% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for AVTX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER144.6% · 74 holders
QUALITY / COMPOUNDER20.6% · 5 holders
DEALER / BANK16.3% · 13 holders
TACTICAL / MACRO11.0% · 4 holders
PASSIVE / INDEX2.8% · 3 holders
SYSTEMATIC / QUANT2.0% · 4 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for AVTX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention AVTX yet.